Purpura Hemorrhagica in Mules: Immune-Mediated Vasculitis After Infection

Purpura hemorrhagica is a severe immune-mediated vasculitis, which means the mule's immune system forms complexes that damage small blood vessels. In equids, it is most often linked to recent exposure to Streptococcus equi, the bacterium that causes strangles. As blood vessels become inflamed and leaky, fluid and blood components move into surrounding tissues, causing dramatic swelling, petechiae, bruising, and sometimes tissue injury.

Although most published guidance is based on horses, the same disease process can affect mules and donkeys because they are equids. In practical terms, your vet will usually approach a mule with purpura hemorrhagica similarly to a horse, while adjusting handling, dosing, and monitoring to the individual patient.

This condition can progress quickly. Mild cases may show limb or head edema and small hemorrhages on the gums. More serious cases can involve painful skin swelling, muscle damage, sloughing of skin, colic-like signs, difficulty breathing, or complications related to the original infection. Early veterinary care gives your mule the best chance of stabilizing before blood vessel damage becomes widespread.

The most common trigger is recent streptococcal infection, especially strangles caused by Streptococcus equi subsp. equi. After infection, the immune system may produce antibodies that bind bacterial proteins. In some equids, those immune complexes deposit in vessel walls and trigger a type III hypersensitivity reaction, leading to vasculitis, edema, and hemorrhage.

Less commonly, purpura hemorrhagica has been reported after other antigenic stimulation, including strangles vaccination, equine influenza exposure, or chronic draining wounds. That does not mean vaccines are broadly unsafe. It means your vet may weigh vaccine timing and risk carefully in a mule with a recent history of strangles or a prior severe vaccine reaction.

Not every mule exposed to strangles develops purpura hemorrhagica. The reaction appears to depend on the individual's immune response, recent exposure history, and antibody status. In many cases, the syndrome appears within weeks of infection or vaccination rather than during the earliest stage of illness.

Your vet diagnoses purpura hemorrhagica by combining the history, physical exam, and targeted testing. The history often includes recent strangles, nasal discharge, swollen lymph nodes, exposure to infected equids, or recent vaccination. On exam, your vet looks for characteristic edema, petechiae, bruising, pain, fever, and any sign that the airway or muscles are involved.

Common tests include a CBC, chemistry panel, and often fibrinogen or other inflammatory markers to assess inflammation, protein loss, dehydration, muscle injury, and complications. Because strangles is a common trigger, your vet may also recommend PCR or culture from a nasal, nasopharyngeal, abscess, or guttural pouch sample, and in some cases a Streptococcus equi M-protein antibody titer to support recent exposure.

Diagnosis also means ruling out other causes of edema, petechiae, or vasculitis. Depending on the case, your vet may consider equine viral arteritis, equine infectious anemia, severe cellulitis, liver disease with low protein, anaplasmosis, or other systemic infections. If the mule is very swollen, painful, or unstable, referral and hospitalization may be the safest path because these cases can deteriorate quickly.

Prevention focuses first on reducing strangles exposure. Good biosecurity matters: isolate new arrivals, avoid shared water buckets and tack during outbreaks, monitor temperatures in exposed equids, and work with your vet on testing if a mule may be a carrier. Because silent carriers can harbor Streptococcus equi in the guttural pouches, outbreak control sometimes requires more than watching for nasal discharge.

Vaccination decisions should be individualized. In equids with a history of purpura hemorrhagica, recent strangles, or high concern for adverse immune reactions, your vet may recommend a more cautious plan rather than routine vaccination on a fixed schedule. The goal is not to avoid prevention altogether, but to match prevention to the mule's risk profile.

Prompt treatment of respiratory infections, draining wounds, and other inflammatory conditions may also reduce immune stimulation that could contribute to vasculitis. If your mule has had purpura hemorrhagica before, keep clear medical records and tell any veterinarian involved in future care. That history can change how your vet approaches testing, isolation, and vaccine timing.